The Sigma‐1 Gene as a Prognostic Marker in Chemotherapy‐Treated Breast Cancer‐Antagonists' Synergism With Paclitaxel In Vitro
Taken together, our results indicate that S1R is a potential biomarker for the response to nChT and that targeting Sig1R could enhance Px efficacy while deterring key metastatic mechanisms.
Authors
- Stephen T. Safrany (ORCID: https://orcid.org/0000-0002-9592-4112)
- Preeti Borde
- Ebrahim Rajab (ORCID: https://orcid.org/0000-0002-0085-5338)
- Alia Abdulla
Institutions
- Royal College of Surgeons in Ireland - Bahrain (BH)
- Keele University (GB)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/cam4.71376
- Primary Topic
- Pharmacological Receptor Mechanisms and Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Royal College of Surgeons in Ireland